<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-biomolecules-11-00350">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bond</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rogers</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Peters</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hoyle</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Miners</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Moxham</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Thokala</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Wailoo</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimerâ€™s disease (review of Technology Appraisal No. 111): A systematic review and economic model</article-title>
  <source>Health Technol. Assess.</source>
  <year>2012</year>
  <volume>16</volume>
  <fpage>1</fpage>
  <lpage>470</lpage>
  <pub-id pub-id-type="doi">10.3310/hta16210</pub-id>
 </element-citation>
</ref>
